Noven Pharmaceuticals, Inc. and its Noven Therapeutics subsidiary are mutually committed to maintaining the highest standards of professionalism, ethics, integrity, and compliance across their respective businesses, activities, and interactions.
Code of Business Conduct and Ethics
Noven has adopted a Code of Business Conduct and Ethics that applies to our directors, officers, and employees.
As part of our commitment to deliver meaningful benefits to patients using our products and to conduct business honestly, lawfully, and ethically, Noven has established a Comprehensive Compliance Program:
Noven Comprehensive Compliance Program
California Declaration of Compliance
California Supply Chains Act Disclosure
The 2010 California Transparency in Supply Chains Act requires companies to disclose their efforts to eradicate slavery and human trafficking from their supply chain. Noven opposes slavery and human trafficking and is committed to conducting its business in a lawful and ethical manner and requires its suppliers to conduct themselves in the same manner.
Human Rights Policy
Sustainable Procurement Guidelines
Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.
Year of Incorporation:
Chief Executive Officer:
Dr. Naruhito Higo
Media, General Business
& Other Inquiries:
Partnering and Other Business Development Opportunities
Sr. Manager –
Corporate Social Responsibility
Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.
Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.
Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.